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Abstract
Background: The biological basis of pain in chronic pancreatitis is poorly understood. Mast cells
have been implicated in the pathogenesis of pain in other conditions. We hypothesized that mast
cells play a role in the pain of chronic pancreatitis.
We examined the association of pain with mast cells in autopsy specimens of patients with painful
chronic pancreatitis. We explored our hypothesis further using an experimental model of
trinitrobenzene sulfonic acid (TNBS) -induced chronic pancreatitis in both wild type (WT) and mast
cell deficient mice (MCDM).
Methods: Archival tissues with histological diagnoses of chronic pancreatitis were identified and
clinical records reviewed for presence or absence of reported pain in humans. Mast cells were
counted.
The presence of pain was assessed using von Frey Filaments (VFF) to measure abdominal
withdrawal responses in both WT and MCDM mice with and without chronic pancreatitis.
Results: Humans with painful chronic pancreatitis demonstrated a 3.5-fold increase in pancreatic
mast cells as compared with those with painless chronic pancreatitis.
WT mice with chronic pancreatitis were significantly more sensitive as assessed by VFF pain testing
of the abdomen when compared with MCDM.
Conclusion: Humans with painful chronic pancreatitis have an increased number of pancreatic
mast cells as compared with those with painless chronic pancreatitis. MCDM are less sensitive to
mechanical stimulation of the abdomen after induction of chronic pancreatitis as compared with
WT. Mast cells may play an important role in the pathogenesis of pain in chronic pancreatitis.
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Background
Although pain is the presenting symptom of most patients
with chronic pancreatitis, its neurobiological basis
remains poorly understood [1]. In the past, investigators
have focused on the role of anatomical abnormalities
such as a strictured pancreatic duct or narrowed intrapa-
renchymal ducts. However, mechanical decompression
techniques such as endoscopic stent placement or even
surgical pancreatojejunostomy frequently do not provide
a permanent solution to the pain [1]. More recently, inves-
tigators have begun focusing on the role of neurotransmit-
ters and neurotrophins such as substance P and nerve
growth factor with known or suspected roles in nocicep-
tive signaling and/or sensitization and have reported an
increased expression of several of them in the pancreas of
patients with painful chronic pancreatitis [2]. Mast cells
are also increased in both acute and chronic pancreatitis
[3,4] but their role in the generation of pain in pancreati-
tis has not been investigated.
We hypothesized that mast cells are involved in the patho-
genesis of pain in chronic pancreatitis. This hypothesis is
based on the following observations. First, mast cells have
been associated with human conditions in which pain is
a predominant symptom. Interstitial cystitis and irritable
bowel syndrome are both conditions in which pain is out
of proportion to the objective pathological findings [5,6].
In both conditions, an increase in the number of mast
cells has been described in the bladder and the colon,
respectively [5,6]. Further, mast cells are frequently found
in close proximity to nerves in the intestinal mucosa and
the bladder [7-9]. This has also been observed in the pan-
creas – the total number of mast cells was significantly
higher in pancreatic tissue from patients with chronic
pancreatitis than in the normal pancreatic controls [3].
One of the preferential locations of mast cells was around
and within the perineurium of nerve fibers in tissue sam-
ples of patients with chronic pancreatitis, suggesting the
potential for interactions between mast cells and the nerv-
ous system. Lastly, there is evidence for bi-directional
functional communication between mast cells and nerves
[10-12]. Mast cells can not only release mediators that
increase excitability of neurons but in turn, neurotrans-
mitters such as substance P can trigger mast cell degranu-
lation [10]. Mast cells may therefore contribute to the
pathogenesis of pain in pancreatitis through degranula-
tion products that can sensitize pancreatic afferent neu-
rons in an ongoing vicious circle of neuronally mediated
mast cell degranulation.
Our first aim was to analyze the presence and distribution
of mast cells in autopsy specimens of chronic pancreatitis
and study the correlation, if any, with historical documen-
tation of pain. We then explored our hypothesis further
using an experimental model of trinitrobenzene sulfonic
acid (TNBS)-induced chronic pancreatitis in both wild
type and KitW/KitW-v mice, a strain deficient in mast cells
(MCDM).
Methods
Data collection autopsy study
Autopsy records from the University of Texas Medical
Branch from the years 1993 to 2000 were searched elec-
tronically for the term "pancreatitis." One-hundred sixty-
six patients were identified of which 26 patients carried an
autopsy diagnosis of chronic pancreatitis and 140 patients
carried a diagnosis of acute pancreatitis. The medical
charts from patients with an autopsy diagnosis of chronic
pancreatitis were reviewed for documentation of a medi-
cal history of chronic pancreatitis. If no such documenta-
tion was present in the chart, patients were excluded from
the study (12/26). Thus, 14/26 patients with both a docu-
mented history and an autopsy based diagnosis of chronic
pancreatitis, were included in the study. Patients were cat-
egorized as painful chronic pancreatitis (8/26) when they
fulfilled one of the following criteria: a documented his-
tory of chronic abdominal pain clinically attributed to
chronic pancreatitis that required the use of narcotics,
and/or frequent admissions for recurrent abdominal pain
clinically attributed to chronic pancreatitis, and/or a sur-
gical or endoscopic procedure for refractory abdominal
pain clinically attributed to chronic pancreatitis. Patients
were categorized as non-painful chronic pancreatitis (6/
26) if patients did not fit any of the criteria listed under
painful chronic pancreatitis. In addition, the following
data were collected: demographic factors (age and race),
cause of death, comorbidities, clinical history of pancrea-
titis, etiology of pancreatitis, diagnostic studies support-
ing a diagnosis of pancreatitis (amylase, lipase,
calcifications on abdominal plain film, CT-scan, ultra-
sound or ERCP). Human pancreatic control tissue was
obtained from 8 arbitrarily chosen patients of whom the
autopsy records recorded acute myocardial infarction as
the cause of death. Their medical records were reviewed to
ensure that they did not have a clinical history of pancre-
atitis. Therefore there were three categories of patients:
one with painful chronic pancreatitis, one with non-pain-
ful chronic pancreatitis and non-pancreatitis controls. A
pathologist, blinded to the group assignment, verified all
histological diagnoses and counted mast cells on a
Giemsa stained tissue section (average of 10 high-power
randomly chosen (40X) fields per specimen). The proto-
col was approved by the Institutional Review Board of the
University of Texas Medical Branch.
Mice strains
All mice were purchased from the Jackson Laboratory (Bar
Harbor, ME). Male mice were used from the following
strain: WBB6F1/j-KitW/KitW-v (MCDM) and the respective
littermate control mouse strain, KitW-v – +/+ (WT). TheBMC Gastroenterology 2005, 5:8 http://www.biomedcentral.com/1471-230X/5/8
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mice were 3 months of age at the onset of the experiment
with body weights of 25–30 gram.
Experimental protocols involving mice were approved by
our Institutional Animal Care and Use Committee
(IACUC) in accordance with the guidelines provided by
the National Institutes of Health.
Induction of chronic pancreatitis
Mice were anesthetized with sodium Nembutal (50 mg/kg
body weigh, i.p.) Following a midabdominal laparotomy,
a canula was introduced into the common pancreato-bil-
iary duct; the duct was ligated proximally and distally to
ensure perfusion into the pancreas and prevent entry of
the injected substance into the liver or duodenum. 0.1 ml
of 1% TNBS in phosphate buffered saline (PBS)-10% eth-
anol, pH 8, was infused into the pancreas (modified after
Puig-Divi [13]). The canula was removed and the abdo-
men closed. Control mice were treated in the exact same
fashion but were perfused with saline instead (Figure 1).
Mice were sacrificed 8 weeks after surgery.
Von Frey Filament (VFF) measurements
VFF hairs consist of a series of filaments of increasing
diameter that produce increasing sensations of touch
when applied to the skin. When the tip of a fiber of given
length and diameter is pressed against the skin, the force
of application increases until the fiber bends. After the
fiber bends, continued advance creates more bend, but
not more force of application. This principle makes it pos-
sible to apply a reproducible force to the skin surface. VFF
testing is an established behavioral pain assay used to
determine mechanical pain thresholds in somatic pain.
More recently, VFF testing has been used as a surrogate
marker for visceral pain [14,15].
Mice were placed in a cage with a mesh floor and habitu-
ated to the environment for 30–60 minutes. Measure-
ments were taken from the abdomen and the plantar
surface of both hindpaws over a period of three weeks
prior to the surgery and for a total of three weeks after the
surgery (Figure 1). VFF filaments of various caliber were
applied to the mid-abdomen in ascending order 10 times,
each for 1–2 seconds with a 10 second interval. A response
was defined as: a) sharp retraction of the abdomen; b)
immediate licking or scratching of site of application of
hair; or c) jumping. The response frequency was defined
as the total number of responses out of 10 applications
(expressed as a percentage) to the skin per filament. An
investigator blinded to the different treatment groups per-
formed the behavioral testing.
Pancreatic histology
Fresh specimens of the mouse pancreas were fixed in 10%
formaldehyde in PBS pH 7.4 containing 1 mM MgCl2 at
4°C overnight. Sections from paraffin-embedded speci-
mens were stained with hematoxyline and eosin and
observed under a light microscope. Pathological changes
were scored based on a scale described by Tito et al. by a
pathologist blinded to the different treatment groups
[16].
Data expression and statistical analysis
Comparisons of the number of mast cells in autopsy spec-
imen were analyzed using the Mann-Whitney U test.
For each behavioral experiment (see figure 1), the average
response frequency was calculated as the mean of the
mean response frequencies for each mouse (across four
measures). The "post-pre response frequency" was calcu-
lated by subtracting the pre-surgical average response fre-
quency from the post-surgical average response frequency.
To assess the independent effect of TNBS on VFF response
(ie. to control for the effect of the surgery itself), the post-
pre response frequency for TNBS infusion was compared
with the post-pre response frequency for saline infusion.
This comparison was performed using analysis of variance
for a two-factor experiment with repeated measures on
time at each level of force for each type of mice (WT and
MCDM). The two factors were induction of pancreatitis or
not (TNBS or saline, respectively) and time (pre-surgical
or post-surgical). TNBS infusion was considered to have
had an independent effect on the VFF response if the post-
pre response frequency was greater for TNBS than for
saline infusion.
Fisher's least significant difference procedure was used for
multiple comparisons of least squares means with
Experimental design Figure 1
Experimental design All mice underwent pre and post 
surgical VFF testing. For the VFF testing, 4 measures were 
taken for each mouse. WT and MCDM were randomized to 
either saline or TNBS perfusion into the pancreatic duct.
Pre-surgical (baseline) VFF testing of all WT and MCDM
WT MCDM
Saline (n=4) TNBS (n=4) saline (n=4) TNBS (n=6)
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Bonferroni adjustment for number of comparisons. All
effects and interactions were assessed at the 0.05 level of
significance. Data analysis was conducted using PROC
MIXED with LSMEANS options in SAS®, Release 8.2 [SAS
Institute Inc., SAS/STAT® User's Guide, Version 8, Cary,
NC: SAS Institute Inc., 1999].
Results
Autopsy data
Patient demographics are summarized in Table 1. Alcohol
abuse was the most common cause for pancreatitis in
both groups. Analysis of our results, using the Mann-
Whitney U test, revealed significantly more mast cells in
patients with a history of painful chronic pancreatitis (n =
8) when compared to patients with either non-painful
chronic pancreatitis (n = 6) (33.8 vs 9.4 average mast cell
count/10 high power fields; p < 0.01) or controls (n = 8),
(33.8 vs 6.1 average mast cell count/10 high power fields;
p < 0.01) (Figure 2). The increased number of mast cells
in patients with painful pancreatitis was noted predomi-
nantly in interstitial areas and, to a lesser degree, in the
periacinar space.
Withdrawal responses to mechanical stimulation of the 
abdomen and paw after induction of chronic pancreatitis
Figure 3 shows the post-pre surgical response frequency
for both WT and MCDM. TNBS had a significant inde-
pendent effect on abdominal VFF response in WT mice at
the force levels 4 and 8 mN (p = 0.007 and 0.037, respec-
tively) (Figure 3A). There was a trend towards a significant
effect at the force level of 16 mN (p = 0.066). In contrast,
for MCDM, TNBS had no significant effect on abdominal
VFF response at any force level (Figure 3B). There was no
significant TNBS effect on VFF response in the left
Table 1: Patient demographics
A Patients with chronic pancreatitis and pain
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8
A g e 5 45 83 86 36 16 53 87 3
Race/gender B-M C-M LA-M C-M C-F B-M C-M C-M
Cause of death arrhythmia AMI Cardio-myopathy pneumonia/ESLD liver-failure CAD/cachexia Gibleed/ARDS PE
Comorbidities ESRD/CP/HCV COPD/CP CP/sp Puestow cirrhosis/COPD/
CP
HTN/CP HTN/CP CP/sp Puestow COPD/CAD/CP/
Laryngeal ca
CP etiology ETOH ETOH chronic 
cholelithiasis
ETOH ETOH ETOH ETOH ETOH
CP imaging CT CT/ERCP CT/ERCP CT CT/ERCP CT/ERCP CT/ERCP CT
Enzymes no no yes no no no yes yes
Insulin no no yes no no yes yes no
Narcotics vicodin vicodin vicodin vicodin vicodin darvocet vicodin vicodin
B Patients with chronic pancreatitis without pain
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
A g e 5 67 25 66 04 54 0
Race/gender C-M C-F C-M C-M C-F C-F
Cause of death AMI sepsis AMI pneumonia sepsis unknown
Comorbidities CP CP IDDM/CP CAD/CM/IDDM/
CP
HIV/asthma/HTN CP
CP etiology ETOH ETOH idiopathic idiopathic ETOH ETOH
CP imaging CT/ERCP RUQ-US CT CT CT CT
Enzymes yes yes no yes no yes
Insulin yes no yes yes no yes
C Control group
Control 1 Control 2 Control 3 Control 4 Control 5 Control 6
A g e 5 65 67 35 15 37 6
Race/gender C-M LA-F C-F LA-M C-M C-F
Cause of death AMI AMI arrhythmia AMI PE AMI
Comorbidities HTN CAD CAD/HTN/DM DM CAD CAD/HTN/DM
C = caucasian; LA = latin-american; B = black; M = male; F = female; ESRD = end stage renal disease; HCV = hepatitis C virus; COPD = chronic 
obstructive pulmonary disease; AMI = acute myocardial infarction; ESLD = end stage liver disease; HTN = hypertension; CAD = coronary artery 
disease; ca = cancer; ETOH = alcohol; ERCP = endoscopic retrograde cholangiopancreatogram; IDDM = insulin-dependent diabetes mellitus; CM = 
cardiomyopathy; HIV = human immunodeficiency virusBMC Gastroenterology 2005, 5:8 http://www.biomedcentral.com/1471-230X/5/8
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Mast cell in painful and nonpainful chronic pancreatitis Figure 2
Mast cell in painful and nonpainful chronic pancreatitis A Histology of autopsy specimen. Giemsa staining of autopsy 
specimens of controls and of patients with chronic pancreatitis (CP) both with and without pain. Large images represent 40× 
magnification while the inserts are 100× magnifications of mast cells. Scale bars represent 20 µM. Arrows point at mast cells. B 
Autopsy specimens of patients with a history of chronic abdominal pain contained a significantly higher number of mast cells as 
compared to specimens of patients with chronic pancreatitis without a history of abdominal pain (34.1 +/- 7 vs 8.6 +/- 2.9; P < 
0.01) or to control specimens (34.1 +/-7 vs 6.6 +/- 1.4; P < 0.01).
0
10
20
30
40
50
normal CP + pain CP - pain
a
v
e
r
a
g
e
m
a
s
t
c
e
l
l
c
o
u
n
t
/
1
0
H
P
f
i
e
l
d
s
/
p
a
t
i
e
n
t
A
B
* * p<0.01BMC Gastroenterology 2005, 5:8 http://www.biomedcentral.com/1471-230X/5/8
Page 6 of 13
(page number not for citation purposes)
Abdominal VFF WT and MCDM Figure 3
Abdominal VFF WT and MCDM Post-pre response frequency was calculated by subtracting the average pre-surgical 
response frequency from the average post-surgical response frequency for WT mice (A) and MCDM (B). P-values are for the 
comparison of the post-pre response frequency for TNBS infusion versus post-pre response frequency for saline infusion.
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Left Hindpaw VFF WT and MCDM Figure 4
Left Hindpaw VFF WT and MCDM Post-pre response frequency was calculated by subtracting the average pre-surgical 
response frequency from the average post-surgical response frequency for WT mice (A) and MCDM (B). P-values are for the 
comparison of the post-pre response frequency for TNBS infusion versus post-pre response frequency for saline infusion.
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Histology (H&E) of mice with chronic pancreatitis Figure 5
Histology (H&E) of mice with chronic pancreatitis A H&E staining of the pancreas of WT and MCDM 4 weeks after 
infusion of TNBS into the pancreatic duct. Images represent 40× magnification; scale bars represent 20 µM. Fibrosis and inflam-
matory infiltrates are present. B Average histological scores for WT and MCDM. There is no significant difference in histologi-
cal scores between WT and MCDM (P = NS).
WT MCDM
0.0 1.0 2.0 3.0 4.0
edema
inflammation
parenchymal loss
vacuolization
Inflammatory score
WT
MCDM
A
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hindpaw for either WT mice or MCDM (Figure 4). Data
not shown for the right hindpaw.
Histological analysis of mice pancreas following TNBS 
injection
Pancreatic histology confirmed the presence of chronic
pancreatitis in both WT and MCDM with marked fibrosis,
inflammatory infiltrates and ductular proliferation
mimicking changes seen in human chronic pancreatitis
(Figure 5A). The pancreas of saline treated controls was
normal. There was no significant difference in the overall
inflammatory scores between the WT and MCDM (Figure
5B). An increased number of mast cells were counted in
WT mice with chronic pancreatitis compared to saline
Histology (Giemsa) of mice with chronic pancreatitis Figure 6
Histology (Giemsa) of mice with chronic pancreatitis A Giemsa staining of the pancreas of WT and MCDM 4 weeks 
after infusion of TNBS into the pancreatic duct. Large images represent 40× magnification while the inserts are 100× magnifica-
tions of mast cells. Scale bars represent 20 µM. B Significantly more mast cells are present in the pancreatic tissue of mice 
treated with TNBS when compared with saline treated controls (* P < 0.05).
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treated controls (5.6 vs 1.5; p = 0.05) (Figure 6). As to be
expected, no mast cells were present in pancreas of
MCDM.
Discussion
Chronic pancreatitis has been defined as a continuing
inflammatory disease of the pancreas characterized by
irreversible morphologic changes that typically cause pain
and/or permanent loss of function [17]. The pathogenesis
of pain in this condition remains to be satisfactorily estab-
lished. We examined the association, if any, of pain with
mast cells as quantified in autopsy specimens of patients
with a history of painful and non-painful chronic pancre-
atitis and normal controls. Significantly more mast cells
were present in pancreatic tissue from patients with a his-
tory of painful chronic pancreatitis, indicating an associa-
tion with this condition and a potential role for these cells
in the pathogenesis of pain in painful chronic
pancreatitis.
There are clearly limitations to a retrospective, autopsy-
based study such as the one we report here. For instance,
we do not know whether pain was present at the time of
death and there was incomplete information on the dif-
ferent patterns of pain. Also, our findings pertain mainly
to patients with a history of alcoholic pancreatitis. Never-
theless, our findings do suggest an association of painful
chronic pancreatitis with an increased number of mast
cells. This observation provided the rationale for further
experimental testing, which we performed in mice. We
first developed a model of chronic pancreatitis in mice fol-
lowing a modified protocol first described by Puig- Divi et
al. [13]. Histological changes consisted of periductal and
lobular fibrosis, duct stenosis, chronic inflammatory cell
infiltrates, and gland atrophy, mimicking features of
chronic pancreatitis in humans. Significantly more mast
cells were present in WT mice with chronic pancreatitis,
adding to the validity of this model for use in studies on
the role of mast cells in pancreatitis. Both WT and MCDM
developed histological changes consistent with chronic
pancreatitis, indicating that the elimination of mast cells
did not modulate the animals' ability to mount an inflam-
matory response. Therefore, any changes observed in pain
behavior are unlikely to stem from differences in underly-
ing inflammation.
Next we determined whether this mouse model could be
used to study behavioral differences associated with
chronic pancreatitis. The assessment of spontaneous pain
in a visceral organ presents significant difficulties. We
have used a behavioral method to assess this, which relies
on the association of visceral pain with sensitization of
somatic regions of the body that share segmental innerva-
tion at the level of the spinal cord (referred pain). This
somatic sensitization can be quantified using VFF to stim-
ulate the somatotopically appropriate abdominal region
and measuring the abdominal withdrawal response. Thus,
VFF testing of the anterior abdominal wall can be used as
a surrogate marker for visceral pain. Although this is the
first time that this technique has been used for the meas-
urement of referred visceral hyperalgesia in a mouse
model of chronic pancreatitis, this method has previously
been described and validated to assess the severity of
referred visceral pain for models of colonic hypersensitiv-
ity [14] as well as rat models of acute necrotizing pancre-
atitis [15] and chronic pancreatitis [18]. The abdominal
VFF response was compared to the hind paw response to
assess the specificity of the interventions to the pancreas.
TNBS treated mice, but not the saline control, developed
increased abdominal wall withdrawal responses to VFF
testing when compared to baseline, suggesting the devel-
opment of force-dependent referred hyperalgesia of the
abdominal wall in WT mice. There was no evidence of
referred hyperalgesia in the hindpaws, suggesting that the
measured effect on abdominal withdrawal is specific for
an intra-abdominal origin of the pain. Vera-Portocarrero
et al. previously described similar findings, increased
withdrawal frequency after VFF stimulation to the abdom-
inal area, in a rat model of chronic pancreatitis [18]. These
behavioral changes were abrogated by morphine. Rats
that demonstrated behavioral changes also expressed
increased substance P expression in the nociceptive layers
of the spinal cord, suggestive of central nociceptive
changes.
Mast cells produce a variety of degranulation products in
the setting of inflammation that may activate and/or
sensitize primary nociceptive neurons. The neurotrophin
growth factor (NGF) is one such product [19-22]. NGF is
released in the setting of inflammation and can not only
function as a chemoattractant for other mast cells, but it
can also trigger mast cell degranulation [23]. We are spec-
ulating that NGF production in the inflamed pancreas is
responsible for plastic changes in the sensory neurons by
activating proalgesic receptors and channels such as the
NGF receptor tyrosine kinase A (TrkA) and Transient
Receptor Potential Family V receptor 1 (TRPV1; previously
known as VR1) thereby contributing to the generation of
pain [24-26]. Similarly, other mast cell degranulation
products such as tryptase and histamine are capable of
modulating neuronal function [27-32]. Tryptase may
directly activate the proteinase-activated receptor-2 (PAR-
2), a G-protein coupled receptor expressed by pancreatic
nerves, important in the pathogenesis of pain in
pancreatitis [33,34]. Although the role for mast cells in the
mediation of visceral nociceptive signaling needs to be
explored further, we speculate that mast cell products
released in pancreatitis, contribute to the development of
pain by direct effects on nociceptors located on pancreatic
afferent neurons (Figure 7).BMC Gastroenterology 2005, 5:8 http://www.biomedcentral.com/1471-230X/5/8
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However, before concluding a definite role for mast cells
from our experimental data, it should be noted that
MCDM carry a spontaneous mutation for tyrosine kinase
receptor c-kit which not only produces a deficiency of
mast cells but may have an independent effect on the
function of sensory neurons, which are known to express
it [35]. Therefore, it remains to be determined whether the
detected differences in nociceptive responses is due to the
absence of mast cells per se or a yet unknown change in
the responsiveness of sensory neurons due to a congenital
lack of the c-kit receptor. Reconstitution of mast cells into
the MCDM mice should restore their nociceptive
responses close to the wild type phenotype.
Conclusion
Our data should increase awareness of the importance of
mast cells in the pathogenesis of painful inflammatory
Proposed involvement of mast cells in nociceptive signaling in pancreatitis Figure 7
Proposed involvement of mast cells in nociceptive signaling in pancreatitis In pancreatitis, mast cells may migrate to 
sites of inflammation, in response to release of mast cell chemoattractants. Mast cell degranulation products may modulate 
neurotransmission directly by activating proalgesic receptors and channels such as trka (NGF), TRPV1 (NGF) and PAR-2 (tryp-
tase and trypsin).
Mast Cells
TrkA
TRPV1
Nociceptor
Neurotransmitters PAR-2
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conditions such as chronic pancreatitis and encourage
experimental studies for further testing of this hypothesis.
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